Earnings History Data for Immunic, Inc. (IMUX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Immunic, Inc.
Immunic Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis and psoriasis. The company's product candidate consists of IMU-838, IMU-935 and IMU-856 which are in clinical stage. Immunic Inc., formerly known as Vital Therapies Inc., is based in San Diego, United States.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-11-2024 | PM | IMUX | Immunic, Inc. | 107.19 | -0.24 | -0.22 | -0.51 | Immunic GAAP EPS of -$0.24 misses by $0.02 [11/7/2024 6:34 AM] |
1.17 | -0.01 (-0.85%) |
1.18 | 0.0 (0.00%) |
0.95 - 2.11 | 1,457,291 | 810,000 | 24,450 | ||
08-08-2024 | PM | IMUX | Immunic, Inc. | 114.40 | -0.21 | -0.23 | -0.54 | Immunic GAAP EPS of -$0.21 beats by $0.02 [8/8/2024 6:48 AM] |
1.32 | 0.15 (12.82%) |
1.25 | 0.08 (6.84%) |
0.95 - 2.00 | 297,707 | 260,000 | 16,189 | ||
08-05-2024 | PM | IMUX | Immunic, Inc. | 120.50 | -0.25 | -0.27 | -0.58 | Immunic GAAP EPS of -$0.30 misses by $0.04 [5/8/2024 6:34 AM] |
1.27 | -0.11 (-7.97%) |
1.32 | -0.06 (-4.35%) |
0.95 - 3.11 | 174,829 | 180,000 | 12,050 | ||
22-02-2024 | PM | IMUX | Immunic, Inc. | 113.31 | -0.48 | -0.51 | -1.63 | Immunic GAAP EPS of -$2.11 misses by $1.60 [2/22/2024 6:34 AM] |
1.21 | -0.07 (-5.86%) |
1.30 | 0.02 (1.56%) |
0.95 - 3.11 | 917,024 | 810,000 | 3,611 | ||
14-11-2023 | PM | IMUX | Immunic, Inc. | 47.27 | -0.51 | -0.55 | -0.69 | Immunic GAAP EPS of -$0.51 beats by $0.04 [11/14/2023 6:30 AM] |
0.9901 | 0.02 (2.15%) |
1.00 | 0.03 (3.17%) |
0.95 - 3.17 | 198,661 | 620,000 | 17,486 | ||
03-08-2023 | PM | IMUX | Immunic, Inc. | 103.46 | -0.54 | -0.52 | -0.72 | Immunic GAAP EPS of -$0.54 misses by $0.01 [8/3/2023 6:42 AM] |
2.13 | -0.03 (-1.39%) |
2.13 | 0.0 (0.00%) |
1.11 - 11.76 | 699,249 | 750,000 | 18,098 | ||
11-05-2023 | PM | 6:30 AM ET (May 11) |
IMUX | Immunic, Inc. | 79.04 | -0.58 | -0.54 | -0.74 | Immunic GAAP EPS of -$0.58 misses by $0.06 [5/11/2023 6:59 AM] |
1.82 | 0.03 (1.96%) |
1.81 | 0.02 (1.21%) |
1.11 - 11.76 | 582,984 | 610,000 | 18,387 | |
23-02-2023 | PM | 6:30 AM ET (Feb 23) |
IMUX | Immunic, Inc. | 89.16 | -1.63 | -0.81 | -0.81 | Immunic GAAP EPS of -$3.78 misses by $0.88 [2/23/2023 6:33 AM] |
1.96 | 0.07 (3.70%) |
1.89 | 0.0 (0.00%) |
1.11 - 12.64 | 719,047 | 990,000 | 13,802 | |
03-11-2022 | PM | 6:30 AM ET (Nov 3) |
IMUX | Immunic, Inc. | 59.60 | -0.69 | -0.64 | -0.76 | Immunic GAAP EPS of -$0.69 misses by $0.03 [11/3/2022 6:37 AM] |
1.61 | -0.10 (-5.85%) |
1.74 | 0.03 (1.67%) |
1.53 - 14.50 | 1,546,733 | 6,830,000 | 64,993 | |
04-08-2022 | PM | 6:30 AM ET (Aug 4) |
IMUX | Immunic, Inc. | 111.78 | -0.72 | -0.68 | -0.82 | Immunic GAAP EPS of -$0.72 in-line [8/4/2022 6:37 AM] |
4.83 | 0.94 (24.16%) |
3.92 | -0.40 (-9.26%) |
2.52 - 14.50 | 746,682 | 90,000 | 51,552 | |
10-05-2022 | PM | 6:30 AM ET (May 10) |
IMUX | Immunic, Inc. | 174.86 | -0.74 | -0.80 | -1.63 | Immunic GAAP EPS of -$0.74 beats by $0.05 [5/10/2022 6:33 AM] |
5.59 | 0.37 (7.09%) |
0.0 | 0.0 (0.00%) |
5.11 - 15.12 | 173,640 | 230,013 | 0 | |
24-02-2022 | PM | 6:30 AM ET (Feb 24) |
IMUX | Immunic, Inc. | 323.66 | -0.81 | -0.73 | -0.46 | Immunic GAAP EPS of -$3.93 misses by $0.04 [2/24/2022 6:40 AM] |
13.24 | 0.08 (0.00%) |
0.0 | 0.0 (0.00%) |
6.96 - 28.21 | 190,275 | 269,083 | 0 | |
04-11-2021 | PM | 6:30 AM ET (Nov 4) |
IMUX | Immunic, Inc. | 253.31 | -0.76 | -0.81 | -0.70 | Immunic EPS beats by $0.02 [11/4/2021 6:41 AM] |
10.25 | 0.26 (2.60%) |
9.99 | 0.0 (0.00%) |
6.96 - 28.21 | 170,087 | 130,000 | 3,912 | |
06-08-2021 | PM | 6:30 AM ET (Aug 6) |
IMUX | Immunic, Inc. | 229.00 | -0.82 | -0.72 | 0.00 | Immunic EPS misses by $0.15 [8/6/2021 6:39 AM] |
9.24 | 1.20 (14.84%) |
7.82 | -0.23 (-2.86%) |
7.69 - 28.21 | 363,077 | 210,000 | 1,156 | |
06-05-2021 | PM | IMUX | Immunic, Inc. | 312.00 | -1.63 | -0.69 | 0.00 | Immunic EPS misses by $0.95 [5/6/2021 6:42 AM] |
11.88 | -2.27 (-16.04%) |
13.91 | -0.24 (-1.70%) |
8.02 - 28.21 | 381,970 | 90,000 | 25 | ||
26-02-2021 | PM | IMUX | Immunic, Inc. | 339.00 | -0.46 | -0.59 | 0.00 | Immunic EPS beats by $0.05 [2/26/2021 6:46 AM] |
15.96 | 0.32 (2.05%) |
15.56 | -0.08 (-0.51%) |
4.19 - 28.21 | 255,349 | 518,759 | 1,100 | ||
05-11-2020 | AH | IMUX | Immunic, Inc. | 316.37 | -0.70 | -0.61 | -0.82 | Immunic EPS misses by $0.07 [11/5/2020 4:57 PM] |
17.09 | -0.26 (-2.40%) |
17.25 | -0.26 (-1.48%) |
4.19 - 23.39 | 220,215 | 266,053 | 1,519 | ||
|